David Kirn - May 2, 2023 Form 4 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Role
Chief Executive Officer, Director
Signature
/s/ August J. Moretti, Attorney-in-Fact for David Kirn
Stock symbol
FDMT
Transactions as of
May 2, 2023
Transactions value $
$0
Form type
4
Date filed
5/4/2023, 08:09 PM
Previous filing
Feb 23, 2023
Next filing
Dec 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FDMT Common Stock Gift $0 -600K -32.27% $0.00 1.26M May 2, 2023 Direct
transaction FDMT Common Stock Gift $0 +600K $0.00 600K May 2, 2023 Family Trusts F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects gifts of shares by the Reporting Person to irrevocable trusts established for the benefit of the Reporting Person's children. The Goldman Sachs Trust Company of Delaware is the Trustee of such trusts.